Back to results
US 2022/0054516 A1Published application
Compounds and pharmaceutical uses thereof
AssigneeSyneuRx International (Taiwan) Corp.
InventorsGuochuan Emil Tsai, Yi-Wen Mao, Lu-Ping Lu, Wei-Hua Chang, Han-Yi Hsieh, Jhe Wei Hu, Tsai-Miao Shih, ChanHui Huang
Life of this patent
Estimating the term…
Abstract
A method of treating coronavirus infection, comprising administering to a subject in need thereof an effective amount of a composition, wherein the composition comprises one or more compounds of Formula (I): or a pharmaceutically acceptable salt thereof.
Claims32
A method of treating coronavirus infection, comprising administering to a subject in need thereof an effective amount of a composition, wherein the composition comprises a compound of Formula (I):
- or a pharmaceutically acceptable salt thereof,
- wherein Ring X is a 5 or 6 membered monocyclic ring, which optionally has one or two heteroatoms selected from the group consisting of N, O, P, and S;
- wherein at least one of R1, R2, R3, R4, R5, and R6, independently is of the formula:
- and the remaining R1, R2, R3, R4, R5, and R6 each, independently, is selected from the group consisting of —OH, —COOH,
- and absent;
- wherein n and o are, independently, 0 or 1;
- wherein m and p are, independently, 1, 2, 3, 4, or 5;
- and
- wherein the compound of Formula (I) has 2 to 35 galloyl moieties, inclusive.
6 more elements
24-30. (canceled)
38-48. (canceled)
Dependencies are inferred from the claim text.